Children's Hospital Colorado
Shelley Miyamoto, MD

Shelley Miyamoto, MD

Jack Cooper Millisor Chair in Pediatric Heart Disease
Director, Cardiomyopathy Program

Cardiology - Pediatric, Pediatrics
Heart Failure, Congenital Heart Disease, Cardiomyopathy

Cardiology - Pediatric, Pediatrics


Heart Failure, Congenital Heart Disease, Cardiomyopathy

"I feel like I'm a good listener. I'm very interested in the symptoms you say your child has and what you're seeing on a daily basis. It plays a very important role in how we decide to treat your child."

- Dr. Shelley Miyamoto

Get to know her background

Undergraduate 1993

University of Iowa

Medical Education 1998

University of Iowa Carver College of Medicine

Residency 2002

Rhode Island Hospital

Fellowship 2005

University of Colorado School of Medicine

Cardiovascular Scholar Award Winner 2006

Awarded for abstract presentation titled, "Cell-specific Responses in an Apoptotic Model of Viral Myocarditis"
American Federation for Medical Research

Fern Primack Heart Who Cares Award 2009

Nominated by peers and colleagues in recognition of dedication to the Heart Institute and Cardiac patient families. Awarded by the Little Hearts Committee
Heart Institute at The Children's Hospital

Medical Student Teaching Award 2010

Medical Student Teaching Award: Best Clinical Correlates.
School of Medicine Class of 2013

Top Doctor in Denver 2015

Voted a 5280 best doctor by my peers in response to the question, "Which physician would you trust to treat you and your family?"
5280 Magazine

For Patients:
My research interest is to identify targeted therapy specific to children suffering from poor heart function. Currently, treatment of children with heart failure is based on what is done for adult patients. Important differences exist between children and adults with heart failure and our goal is to identify treatment options that are appropriate specifically for children.
For Referring Providers:
My research interests include investigation into the molecular level adaptations that occur in the setting of heart failure in children. Specifically in collaboration with colleagues in adult cardiology we are performing investigations utilizing human tissue, primary and stem cell models as well as various animal models to investigate mechanisms specific to the failing pediatric heart. We also are interested in identifying biomarkers of disease, especially circulating microRNAs, as they relate to risk stratification for children with heart disease. I am also active in pediatric heart transplant clinical research. I am interested in outcomes as well as evaluation and management of rejection and transplant coronary artery disease.

Jack Cooper Millisor Chair in Pediatric Heart Disease

Director, Cardiomyopathy Program